Security key
45674E109
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB)
CUSIP: 45674E109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 9,783,925
- Total 13F shares
- 286,664
- Share change
- -21,391,898
- Total reported value
- $599,128
- Price per share
- $2.09
- Number of holders
- 1
- Value change
- -$19,546,322
- Number of sells
- 28
Report period
Q2 2025
Institutions
1
Top holders
1
INAB full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
IN8BIO, INC. SEC filings
IN8BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45674E109
Recent filing periods:
Top shareholders of INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Orin Hirschman |
13D/G
|
— |
4.4%
|
149,895
|
$17,987 | -$725,036 | 30 Jun 2025 | |
| William Tai-Wei Ho |
13D/G
|
— |
3.7%
|
151,223
|
$349,325 | $0 | 30 Jun 2025 | |
| Transcend Partners Opportunity Fund I LLC |
13D/G
|
Transcend Partners Opportunity Fund LLC |
2.6%
|
107,416
|
$248,131 | $0 | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
13D/G
|
Company |
2.6%
from 13D/G
|
2,079,575
|
$345,209 | — | 31 Mar 2025 | |
| BIOS Capital Management, LP |
13F
|
Company |
88%
|
8,600,001
|
$1,427,600 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
58%
|
5,696,202
|
$945,570 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
18%
|
1,802,956
|
$299,291 | — | 31 Mar 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
15%
|
1,450,000
|
$240,700 | — | 31 Mar 2025 | |
| Sigma Planning Corp |
13F
|
Company |
7.2%
|
700,680
|
$116,313 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.8%
|
568,631
|
$94,403 | — | 31 Mar 2025 | |
| Stonegate Investment Group, LLC |
13F
|
Company |
1.8%
|
180,000
|
$29,880 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
93,420
|
$15,508 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.91%
|
88,746
|
$14,732 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.71%
|
69,708
|
$11,572 | — | 31 Mar 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.71%
|
69,301
|
$11,400 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.6%
|
58,504
|
$9,712 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.35%
|
34,279
|
$5,690 | — | 31 Mar 2025 | |
| Overbrook Management Corp |
13F
|
Company |
0.35%
|
33,756
|
$5,604 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
29,450
|
$4,889 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
24,812
|
$4,119 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.21%
|
20,292
|
$3,368 | — | 31 Mar 2025 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.18%
|
17,605
|
$2,922 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.15%
|
15,110
|
$3,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
12,327
|
$2,046 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.12%
|
11,350
|
$1,884 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.1%
|
10,000
|
$1,660 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.08%
|
8,263
|
$1,372 | — | 31 Mar 2025 | |
| Westside Investment Management, Inc. |
13F
|
Company |
0.02%
|
2,000
|
$332 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.01%
|
1,007
|
$167 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
485
|
$81 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
102
|
$17 | — | 31 Mar 2025 | |
| Aaron G.l. Fletcher |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
11,825,804
mixed-class rows
|
$1,289,996 | — | 02 May 2025 | |
| Leslie W. Kreis |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
11,825,804
mixed-class rows
|
$1,289,996 | — | 02 May 2025 | |
| Trishna Goswami |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
440,925
mixed-class rows
|
$6,931 | — | 04 Sep 2024 | |
| Travis Whitfill |
3/4/5
|
Director |
—
class O/S missing
|
42,676
|
— | — | 19 Dec 2024 |
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q2 2025
As of 30 Jun 2025,
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
286,664 shares.
The largest 1 holders included
BIOS Capital Management, LP.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
28
Q2 2025 holders
1
Holder diff
-27
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.